General MedicationsOPHTHALMICGeneric
EPINASTINE HYDROCHLORIDE
EPINASTINE HYDROCHLORIDE
Standard Dose
0.05%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview EPINASTINE HYDROCHLORIDE is listed in Drugs@FDA under application 204055 (ANDA).
Marketing status: Discontinued Active ingredient EPINASTINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.05% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2017-05-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview EPINASTINE HYDROCHLORIDE is listed in Drugs@FDA under application 204055 (ANDA). Marketing status: Discontinued Active ingredient EPINASTINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.05% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2017-05-05 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.